🟢 SAB Biotherapeutics is trading 11% up today amid biotech-sector strength

SAB Biotherapeutics is trading at $2.88, up 10.58%, amid biotech-sector strength.

• The provided market context reports the XBI up 2.10% during the regular session.
• No new company-specific announcement explaining the advance was identified; available evidence points to sector sentiment rather than a company-specific catalyst.
• SAB Biotherapeutics had announced CEO participation in a Chardan healthcare conference on October 20, but that scheduled appearance does not establish a direct cause for the share move.